858-692-3573 info@denovicontx.com

On March 15, 2021, Denovicon Therapeutics & CEO Founder, Scott Bembenek talked on ‘Combining Machine Learning and Molecular Modeling for Enhanced Active Learning in Small-Molecule Drug Design’ at the AI in Drug Discovery 2021.